Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mesoblast Limited - American Depositary Shares (NQ:MESO)

16.87 -0.04 (-0.24%)
Streaming Delayed Price Updated: 1:59 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mesoblast Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
55 Biggest Movers From Friday ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired... 
Via Benzinga
News headline image
Why Mesoblast Limited Stock Is Jumping Today ↗
The company announced positive results from a clinical trial. 
Via The Motley Fool
News headline image
Mid-Afternoon Market Update: Dow Falls 200 Points; Cirrus Logic Shares Plunge ↗
Toward the end of trading Friday, the Dow traded down 0.60% to 33,856.90 while the NASDAQ fell 0.85% to 13,963.27. The S&P also fell, dropping 0.73% to 4,180.66. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Down 2.5%; CryoLife Shares Jump Following Q1 Results ↗
Midway through trading Friday, the Dow traded down 0.71% to 33,820.14 while the NASDAQ fell 0.44% to 14,020.26. The S&P also fell, dropping 0.64% to 4,184.44. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
38 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000... 
Via Benzinga
News headline image
Mesoblast Shares Rise As Remestemcel-L Cuts Mortality In Patients Below 65 Years With COVID-19 Related Respiratory Distress ↗
Mesoblast Limited (NASDAQ: MESO) has announced 60-day results from the randomized controlled trial of remestemcel-L in COVID-19 patients with moderate/severe... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Before 10 a.m. ET on Wednesday, 6 companies hit new 52-week lows. Noteables: The largest company by market cap to set a new 52-week low was Splunk (NASDAQ:SPLK).... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
News headline image
38 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1... 
Via Benzinga
News headline image
52 Biggest Movers From Yesterday ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday morning, 1 company achieved new low for the year. During the first half-hour of trading on Tuesday, the following stock reached new 52-week low... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2021 ↗
Upgrades According to Janney Capital, the prior rating for Texas Capital Bancshares Inc (NASDAQ:TCBI) was changed from Neutral to Buy. Texas Capital Bancshares earned $1.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.